A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
Public ClinicalTrials.gov record NCT00095225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy (Docetaxel or Pemetrexed) or Tarceva (Erlotinib) Compared With Chemotherapy (Docetaxel or Pemetrexed) Alone for Treatment of Recurrent or Refractory Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase II, multicenter, randomized trial is designed to make preliminary evaluations of the efficacy of combining bevacizumab with chemotherapy (docetaxel or pemetrexed) or Tarceva relative to chemotherapy (docetaxel or pemetrexed) alone in patients with previously treated advanced NSCLC.
Study identification
- NCT ID
- NCT00095225
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 122 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2006 (Actual)
- Last update posted
- Jan 29, 2008
2004 – 2006
United States locations
- U.S. sites
- 48
- U.S. states
- 18
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Blood and Cancer Center (TORI) | Bakersfield | California | 93309 | — |
| Bay Area Cancer Research Group | Concord | California | 94520 | — |
| Virginia K. Crosson Cancer Center (TORI) | Fullerton | California | 92835 | — |
| California Cancer Center, Inc | Greenbrae | California | 94904 | — |
| Wilshire Oncology Medical Group (TORI) | Laverne | California | 91750 | — |
| Pacific Shores Medical Group (TORI) | Long Beach | California | 90813-3244 | — |
| UCLA Medical Center PVUB 3360 | Los Angeles | California | 90095 | — |
| Central Hematology Oncology Medical Group (TORI) | Monterey Park | California | 91754 | — |
| North Valley Hematology/Oncology Medical Group (TORI) | Northridge | California | 91328 | — |
| Ventura County Hematology-Oncology Specialists (TORI) | Oxnard | California | 93030 | — |
| Cancer Care Associates Medical Group (TORI) | Redondo Beach | California | 90277 | — |
| UC Davis Cancer Center | Sacramento | California | 95817 | — |
| Kaiser Permanente/ San Diego | San Diego | California | 92120 | — |
| Sansum Santa Barbara Medical Foundation Clinic (TORI) | Santa Barbara | California | 93105 | — |
| Santa Barbara Hematology Oncology Medical Group, Inc (TORI) | Santa Barbara | California | 93105 | — |
| Kaiser Permanente Northern CA | Vallejo | California | 94589 | — |
| San Diego Cancer Center Medical Group (TORI) | Vista | California | 92081 | — |
| Comprehensive Cancer Care Specialist at Boca Raton | Boca Raton | Florida | 33428 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| The Florida Cancer Institute(TORI) | Orlando | Florida | 32804 | — |
| MD Anderson Cancer Ctr- Orlando | Orlando | Florida | 32806 | — |
| Hematology and Oncology of Northeast Georgia, PC (TORI) | Athens | Georgia | 30607 | — |
| Medical Oncology Associates, PC (TORI) | Augusta | Georgia | 30901 | — |
| Suburban Hematology-Oncology Associates (TORI) | Lawrenceville | Georgia | 30045 | — |
| WellStar Cancer Research Office | Marietta | Georgia | 30060 | — |
| Atlanta Cancer Care (TORI) | Roswell | Georgia | 30076 | — |
| Rush-Presbyteriam | Chicago | Illinois | 60612 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Loyola Univ. Medical Center | Maywood | Illinois | 60153 | — |
| Hematology Oncology Consultants | Naperville | Illinois | 60540 | — |
| Oncoloy Hematology Associates of Central Illinois, PC (TORI) | Peoria | Illinois | 61615 | — |
| Norton Healthcare Louisville Oncology | Louisville | Kentucky | 40202 | — |
| Ochsner Cancer Inst. | New Orleans | Louisiana | 70121 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074 | — |
| Methodist Cancer Center-Oncology Research | Omaha | Nebraska | 68114 | — |
| Comprehensive Cancer Centers of Nevada (TORI) | Las Vegas | Nevada | 89109 | — |
| Summit Medical Group Overlook Oncology Center | Summit | New Jersey | 07901 | — |
| Cancer Research of Long Island | Great Neck | New York | 11023 | — |
| Northwestern Carolina Oncology and Hematology | Hickory | North Carolina | 28603 | — |
| Mid Dakota Clinic | Bismarck | North Dakota | 58501 | — |
| Earle A. Chiles Research Institute | Portland | Oregon | 97213 | — |
| Kaiser Permanente Northwest Region | Portland | Oregon | 97227 | — |
| Univ. of Pittsburgh Cancer Center Inst. | Pittsburgh | Pennsylvania | 15232 | — |
| University of Tenn. Cancer Ins | Memphis | Tennessee | 38104 | — |
| The West Cancer Clinic | Memphis | Tennessee | 38120 | — |
| M.D. Anderson | Houston | Texas | 77030 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Internal Medicine Associates of Yakima | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2008 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00095225 live on ClinicalTrials.gov.